Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

US state accuses L’Oreal of concealing cancer risks linked to hair relaxers

A lawsuit accuses L'Oreal of violating state consumer protection laws by failing to warn consumers about an alleged cancer risk in women.

US state accuses L’Oreal of concealing cancer risks linked to hair relaxers

Arizona has initiated legal action against L’Oreal SA and its US subsidiary, claiming the cosmetics giant concealed evidence linking its hair relaxer products to cancer risks in women. This lawsuit marks Arizona's first move against such allegations, as it confronts thousands of similar lawsuits filed by users and their families.

Attorney General Kristin Mayes filed the suit in state court, alleging L’Oreal violated consumer protection laws by marketing these products without warning consumers about potential ovarian and uterine cancer risks. The state seeks penalties, damages, and an order to halt sales until appropriate warnings are provided.

L’Oreal USA maintains its products are safe, dismissing the claims as lacking legal or scientific validity. A 2022 NIH study revealed that frequent use of the products increased the likelihood of uterine cancer among women by over 200%. L’Oreal's spokesman dismissed this study, asserting no causal link exists between product use and the alleged conditions.

The lawsuits, targeting brands like Dark and Lovely and Optimum, seek compensation for plaintiffs' suffering and economic damages for medical bills and product costs. Besides L’Oreal, Revlon and other manufacturers are named in the lawsuits, each denying any cancer link. The multidistrict litigation, involving over 12,000 cases consolidated in Chicago federal court, anticipates trials possibly starting next year.

Written by urgent.news from Free Malaysia Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at freemalaysiatoday.com →

More in Health & Medicine

More from Saturday 12 September →